Gilead Sciences (GILD) FCF Margin (2009 - 2026)
Gilead Sciences posted quarterly FCF Margin of 34.87% for Q1 2026, up 1008.0% year-on-year from 3.15% in Q1 2025, and down 11.48% on a QoQ basis from 39.39% in Q4 2025.
Gilead Sciences (GILD) has 18 years of FCF Margin data on file, last reported at 34.87% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 1008.0% year-over-year to 34.87%; the trailing twelve-month figure through Mar 2026 stood at 34.4% (up 14.0% YoY), and the FY2025 full-year result was 32.12%, down 372.0% from the prior year.
- FCF Margin for Q1 2026 stood at 34.87%, down from 39.39% in the prior quarter.
- Across five years, FCF Margin topped out at 55.24% in Q3 2024 and bottomed at 10.17% in Q2 2025.
- The 5-year median for FCF Margin is 31.62% (2024), against an average of 31.34%.
- Peak annual rise in FCF Margin reached 3208 bps in 2024, while the deepest fall reached 1614 bps in 2024.
- A 5-year view of FCF Margin shows it stood at 32.29% in 2022, then declined by 15 bps to 27.47% in 2023, then soared by 36 bps to 37.36% in 2024, then climbed by 5 bps to 39.39% in 2025, then slipped by 11 bps to 34.87% in 2026.
- The last three FCF Margin figures came in at 34.87% (Q1 2026), 39.39% (Q4 2025), and 50.98% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 15.19% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 6.09% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 23.76% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 17.97% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 17.14% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 34.87% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 93.16% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 6.59% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.87% |
| Dec 31, 2025 | 39.39% |
| Sep 30, 2025 | 50.98% |
| Jun 30, 2025 | 10.17% |
| Mar 31, 2025 | 24.79% |
| Dec 31, 2024 | 37.36% |
| Sep 30, 2024 | 55.24% |
| Jun 30, 2024 | 17.18% |
| Mar 31, 2024 | 31.62% |
| Dec 31, 2023 | 27.47% |
| Sep 30, 2023 | 23.16% |
| Jun 30, 2023 | 33.32% |
| Mar 31, 2023 | 25.74% |
| Dec 31, 2022 | 32.29% |
| Sep 30, 2022 | 38.43% |
| Jun 30, 2022 | 26.50% |
| Mar 31, 2022 | 24.17% |
| Dec 31, 2021 | 42.09% |
| Sep 30, 2021 | 41.96% |
| Jun 30, 2021 | 35.34% |
| Mar 31, 2021 | 38.07% |
| Dec 31, 2020 | 23.38% |
| Sep 30, 2020 | 31.85% |
| Jun 30, 2020 | 47.11% |
| Mar 31, 2020 | 22.80% |
| Dec 31, 2019 | 40.43% |
| Sep 30, 2019 | 43.63% |
| Jun 30, 2019 | 37.94% |
| Mar 31, 2019 | 25.37% |
| Dec 31, 2018 | 36.19% |
| Sep 30, 2018 | 36.54% |
| Jun 30, 2018 | 22.59% |
| Mar 31, 2018 | 40.45% |
| Dec 31, 2017 | 42.58% |
| Sep 30, 2017 | 39.39% |
| Jun 30, 2017 | 47.65% |
| Mar 31, 2017 | 43.15% |
| Dec 31, 2016 | 46.04% |
| Sep 30, 2016 | 55.93% |
| Jun 30, 2016 | 61.48% |
| Mar 31, 2016 | 50.72% |
| Dec 31, 2015 | 66.18% |
| Sep 30, 2015 | 45.93% |
| Jun 30, 2015 | 66.56% |
| Mar 31, 2015 | 73.44% |
| Dec 31, 2014 | 39.02% |
| Sep 30, 2014 | 64.70% |
| Jun 30, 2014 | 62.65% |
| Mar 31, 2014 | 28.09% |
| Dec 31, 2013 | 21.09% |
| Sep 30, 2013 | 25.72% |
| Jun 30, 2013 | 32.81% |
| Mar 31, 2013 | 25.01% |
| Dec 31, 2012 | 16.85% |
| Sep 30, 2012 | 27.97% |
| Jun 30, 2012 | 52.11% |
| Mar 31, 2012 | 18.83% |
| Dec 31, 2011 | 43.27% |
| Sep 30, 2011 | 39.25% |
| Jun 30, 2011 | 42.89% |
| Mar 31, 2011 | 41.83% |
| Dec 31, 2010 | 35.10% |
| Sep 30, 2010 | 37.60% |
| Jun 30, 2010 | 35.44% |
| Mar 31, 2010 | 31.59% |
| Dec 31, 2009 | 45.67% |
| Sep 30, 2009 | 46.76% |
| Jun 30, 2009 | 36.55% |
| Mar 31, 2009 | 31.18% |